Clinical Trial Update: Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Myl1401O + Taxane versus Herceptin + Taxane for first-line metastatic breast cancer; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Myl1401O
• Taxane (paclitaxel or docetaxel)

Snippet

Sponsor: Mylan Inc. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-10-30